Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adverse effects of testosterone replacement therapy: an update on the evidence and controversy
Anthony Grech, John Breck, Joel J. Heidelbaugh
Therapeutic Advances in Drug Safety (2014) Vol. 5, Iss. 5, pp. 190-200
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Testosterone and Cardiovascular Disease
Robert A. Kloner, Culley C. Carson, Adrian S. Dobs, et al.
Journal of the American College of Cardiology (2016) Vol. 67, Iss. 5, pp. 545-557
Open Access | Times Cited: 321
Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis
Chalermrat Bunchorntavakul, K. Rajender Reddy
Alimentary Pharmacology & Therapeutics (2019) Vol. 51, Iss. 1, pp. 64-77
Closed Access | Times Cited: 167
Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people
Janet Barnsley, Gemma L. Buckland, P. E. Chan, et al.
Aging Clinical and Experimental Research (2021) Vol. 33, Iss. 4, pp. 759-773
Open Access | Times Cited: 138
The Role of Testosterone in the Elderly: What Do We Know?
Biagio Barone, Luigi Napolitano, Marco Abate, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3535-3535
Open Access | Times Cited: 74
Testosterone and Cardiovascular Health
Andrew Elagizi, Tobias Köhler, Carl J. Lavie
Mayo Clinic Proceedings (2017) Vol. 93, Iss. 1, pp. 83-100
Open Access | Times Cited: 93
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men
F.M.J. Debruyne, Hermann M. Behre, Claus G. Roehrborn, et al.
BJU International (2016) Vol. 119, Iss. 2, pp. 216-224
Open Access | Times Cited: 91
Development of AAV-Mediated Gene Therapy Approaches to Treat Skeletal Diseases
Chujiao Lin, Matthew B. Greenblatt, Guangping Gao, et al.
Human Gene Therapy (2024) Vol. 35, Iss. 9-10, pp. 317-328
Closed Access | Times Cited: 13
Current pharmacotherapies for sarcopenia
Justin P. Hardee, Gordon S. Lynch
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 13, pp. 1645-1657
Closed Access | Times Cited: 72
Association Between Testosterone Replacement Therapy and the Incidence of DVT and Pulmonary Embolism
Rishi Sharma, Olurinde Oni, Guoqing Chen, et al.
CHEST Journal (2016) Vol. 150, Iss. 3, pp. 563-571
Closed Access | Times Cited: 64
Advances in research on pharmacotherapy of sarcopenia
Yang Feike, Zhijie Liu, Wei Chen
Aging Medicine (2021) Vol. 4, Iss. 3, pp. 221-233
Open Access | Times Cited: 47
Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells
Rachid Safi, Suzanne E. Wardell, Paige Watkinson, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Long-term Exposure to Testosterone Therapy and the Risk of High Grade Prostate Cancer
Jacques Baillargeon, Yong‐Fang Kuo, Xiao Fang, et al.
The Journal of Urology (2015) Vol. 194, Iss. 6, pp. 1612-1616
Closed Access | Times Cited: 58
Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction
Carol A. Podlasek, John P. Mulhall, Kelvin P. Davies, et al.
The Journal of Sexual Medicine (2016) Vol. 13, Iss. 8, pp. 1183-1198
Open Access | Times Cited: 56
The Therapeutic Intervention of Sex Steroid Hormones for Sarcopenia
Le‐Tian Huang, Jiahe Wang
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 34
Enhancing Intrinsic Capacity and Related Biomarkers in Community-Dwelling Multimorbid Older Adults Through Integrated Multidomain Interventions: Ancillary Findings From the Taiwan Integrated Geriatric (TIGER) Trial
Wei‐Ju Lee, Li‐Ning Peng, Ming‐Hsien Lin, et al.
Journal of the American Medical Directors Association (2023) Vol. 25, Iss. 5, pp. 757-763.e4
Closed Access | Times Cited: 14
Pharmaceutical wastewater toxicity: An ignored threat to the public health
Maryam S. Fakhri B, Nasrin Ghassemi-Barghi, Mahdis Moradnia Mehdikhanmahaleh, et al.
Sustainable Environment (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
When is a varicocele repair indicated: the dilemma of hypogonadism and erectile dysfunction?
Marc Goldstein, AliA Dabaja
Asian Journal of Andrology (2015) Vol. 18, Iss. 2, pp. 213-213
Open Access | Times Cited: 45
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth
Michael D. Nyquist, Lisa S. Ang, Alexandra Corella, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 10
Open Access | Times Cited: 32
Sarcopenia and Frailty in Cirrhosis
Chalermrat Bunchorntavakul
Medical Clinics of North America (2023) Vol. 107, Iss. 3, pp. 589-604
Closed Access | Times Cited: 11
Cardiovascular Consequences Unveiled: A Comprehensive Review of Hypopituitarism’s Impact on the Heart
Mengmei Li, Xiaowen Zhen, Hong Sun, et al.
Cardiology in Review (2025)
Closed Access
Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review)
Luka Dobovišek, Marko Hojnik, Polonca Ferk
International Journal of Molecular Medicine (2016) Vol. 38, Iss. 6, pp. 1642-1651
Open Access | Times Cited: 37
Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)
Raymond C. Rosen, Frederick C. W. Wu, Hermann M. Behre, et al.
The Journal of Sexual Medicine (2017) Vol. 14, Iss. 9, pp. 1104-1115
Open Access | Times Cited: 37
Aging-related compensated hypogonadism: Role of metabolomic analysis in physiopathological and therapeutic evaluation
Gustavo Monnerat, Fernando A. C. Seara, Joseph Albert Medeiros Evaristo, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2018) Vol. 183, pp. 39-50
Closed Access | Times Cited: 36
Body composition changes with testosterone replacement therapy following spinal cord injury and aging: A mini review
Tom E. Nightingale, Pamela D. Moore, Joshua Harman, et al.
Journal of Spinal Cord Medicine (2017) Vol. 41, Iss. 6, pp. 624-636
Open Access | Times Cited: 32
The Effects of Transgender Hormone Therapy on Sleep and Breathing: A Case Series
Brian D. Robertson, Brian S. Lerner, Jacob Collen, et al.
Journal of Clinical Sleep Medicine (2019) Vol. 15, Iss. 10, pp. 1529-1533
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top